oncotherics limited is a pharmaceutical company specializing in the development of hypoxia-activated cancer drugs. The company has developed assets for pancreatic and prostate cancer, with a focus on targeting difficult-to-reach hypoxic regions in tumors. oncotherics limited is currently seeking funding for clinical trials and has signed collaboration agreements with the University of Cambridge and the University Health Network for drug development. The company aims to develop new drugs that conventional chemotherapy and radiotherapy cannot reach.
Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie;
Postal Code: 30-348
Contact Details: Purchase the Oncotherics Poland S.A. report to view the information.
Website: http://www.oncotherics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service